426 related articles for article (PubMed ID: 21506141)
1. Early plasmapheresis followed by high-dose γ-globulin treatment saved a severely Rho-incompatible pregnancy.
Isojima S; Hisano M; Suzuki T; Sago H; Murashima A; Yamaguchi K
J Clin Apher; 2011; 26(4):216-8. PubMed ID: 21506141
[TBL] [Abstract][Full Text] [Related]
2. A case of severe Rh (D) alloimmunization treated by intensive plasma exchange and high-dose intravenous immunoglobulin.
Palfi M; Hildén JO; Matthiesen L; Selbing A; Berlin G
Transfus Apher Sci; 2006 Oct; 35(2):131-6. PubMed ID: 17045529
[TBL] [Abstract][Full Text] [Related]
3. Plasmapheresis and intravenous immune globulin for the treatment of D alloimmunization in pregnancy.
Novak DJ; Tyler LN; Reddy RL; Barsoom MJ
J Clin Apher; 2008; 23(6):183-5. PubMed ID: 19003884
[TBL] [Abstract][Full Text] [Related]
4. On the immunologic basis of Rh immune globulin (anti-D) prophylaxis.
Kumpel BM
Transfusion; 2006 Sep; 46(9):1652-6. PubMed ID: 16965599
[No Abstract] [Full Text] [Related]
5. Twin pregnancy complicated by severe hemolytic disease of the fetus and newborn due to anti-g and anti-C.
Trevett TN; Moise KJ
Obstet Gynecol; 2005 Nov; 106(5 Pt 2):1178-80. PubMed ID: 16260562
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment of severe rhesus D-incompatible pregnancy with repeated double-filtration plasmapheresis.
Kamei K; Yamaguchi K; Sato M; Ogura M; Ito S; Okada T; Wada S; Sago H
J Clin Apher; 2015 Oct; 30(5):305-7. PubMed ID: 25413689
[TBL] [Abstract][Full Text] [Related]
7. High-dose intravenous gamma globulin: does it have a role in the treatment of severe erythroblastosis fetalis?
Chitkara U; Bussel J; Alvarez M; Lynch L; Meisel RL; Berkowitz RL
Obstet Gynecol; 1990 Oct; 76(4):703-8. PubMed ID: 2120641
[TBL] [Abstract][Full Text] [Related]
8. Severe Rh alloimmunization and hemolytic disease of the fetus managed with plasmapheresis, intravenous immunoglobulin and intrauterine transfusion: A case report.
Houston BL; Govia R; Abou-Setta AM; Reid GJ; Hadfield M; Menard C; Noyd J; Main S; Zarychanski R
Transfus Apher Sci; 2015 Dec; 53(3):399-402. PubMed ID: 26321100
[TBL] [Abstract][Full Text] [Related]
9. Treatment of D alloimmunization in pregnancy with plasmapheresis and intravenous immune globulin: case report.
Fernández Alba JJ; León R; González-Macías C; Paz A; Prado F; Moreno LJ; Torrejón R
Transfus Apher Sci; 2014 Aug; 51(1):70-2. PubMed ID: 25312036
[TBL] [Abstract][Full Text] [Related]
10. Plasma exchange and high-dose i.v. immunoglobulin in the treatment of severe rhesus hemolytic disease.
Berlin G; Selbing A; Gottvall T
Prog Clin Biol Res; 1990; 337():337-40. PubMed ID: 2112753
[No Abstract] [Full Text] [Related]
11. [Current viewpoints in the anti-D prevention of rhesus alloimmunization in the pregnant woman and of hemolytic disease of the newborn infant (a review of the literature)].
Spasova K; Vŭlcheva B
Akush Ginekol (Sofiia); 1986; 25(3):84-90. PubMed ID: 3019168
[No Abstract] [Full Text] [Related]
12. Transfusion support in the management of immune haemolytic disorders.
Plapp FV; Beck ML
Clin Haematol; 1984 Feb; 13(1):167-83. PubMed ID: 6327130
[No Abstract] [Full Text] [Related]
13. Albumin and packed red blood cells in the treatment of severely isoimmunised pregnancies.
Marianowski L; Debski R; Rokicki T; Pasek K; Lukaszewicz E; Gromadzki J
Mater Med Pol; 1992; 24(4):260-1. PubMed ID: 1308057
[TBL] [Abstract][Full Text] [Related]
14. [Prevention of fetal erythroblastosis with anti-D immunoglobulin].
Rasteński J; Gryglicka M
Acta Haematol Pol; 1988; 19(3-4):239-41. PubMed ID: 3150900
[No Abstract] [Full Text] [Related]
15. [Comparative analysis of the effects to date of the prevention of Rh incompatibility].
Jedwabny A; Suchocki S; Bobrowska G
Acta Haematol Pol; 1988; 19(1-2):56-8. PubMed ID: 2853507
[No Abstract] [Full Text] [Related]
16. The clinical significance of anti-G in alloimmunized pregnant women.
Hadley A; Poole J; Poole G
Transfusion; 1997 Sep; 37(9):985. PubMed ID: 9308650
[No Abstract] [Full Text] [Related]
17. Monitoring and treatment of anti-D in pregnancy.
Bettelheim D; Panzer S; Reesink HW; Csapo B; Pessoa C; Guerra F; Wendel S; Calda P; Sprogøe U; Dziegiel M; Aitokallio-Tallberg A; Koskinen S; Kuosmanen M; Legler TJ; Stein W; Villa S; Villa MA; Trespidi L; Acaia B; Vandenbussche FP; Brand A; de Haas M; Kanhai HH; Gounder D; Flanagan P; Donegan R; Parry E; Sefonte C; Skulstad SM; Hervig T; Flesland Ø; Zupańska B; Uhrynowska M; Lapaire O; Zhong XY; Holzgreve W
Vox Sang; 2010 Aug; 99(2):177-92. PubMed ID: 20331536
[TBL] [Abstract][Full Text] [Related]
18. [Successful emergency treatment of a case with severe hemolytic disease of the newborn due to maternal Rh deletion phenotype-D].
Liu KL; Li BJ; Peng JY
Zhonghua Er Ke Za Zhi; 2006 Jun; 44(6):473-4. PubMed ID: 16836866
[No Abstract] [Full Text] [Related]
19. [Mechanism of action of anti-D-gamma globulin in preventing rhesus alloimmunization in the pregnant woman and hemolytic disease of the newborn infant].
Vŭlcheva B; Spasova K
Akush Ginekol (Sofiia); 1985; 24(2):73-6. PubMed ID: 2990248
[No Abstract] [Full Text] [Related]
20. [Results of the use of plasmapheresis in the treatment of Rh incompatibility].
Czeszyńska M; Cretti A; Rzechuła H; Malinowska-Szutowicz Z
Acta Haematol Pol; 1988; 19(1-2):47-55. PubMed ID: 3149110
[No Abstract] [Full Text] [Related]
[Next] [New Search]
